Boston Scientific (BSX) Com Stk US $0.01

Sell:$103.47Buy:$103.49$0.42 (0.41%)

Prices delayed by at least 15 minutes
Sell:$103.47
Buy:$103.49
Change:$0.42 (0.41%)
Deal now
Prices delayed by at least 15 minutes
Sell:$103.47
Buy:$103.49
Change:$0.42 (0.41%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.

Key people

Michael F. Mahoney
Chairman of the Board, President, Chief Executive Officer
Daniel J. Brennan
Chief Financial Officer, Executive Vice President
Wendy Carruthers
Executive Vice President - Human Resources
Arthur Crosswell Butcher
Executive Vice President, Group President, MedSurg and Asia Pacific
Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiology
Jeffrey B. Mirviss
Executive Vice President and President - Peripheral Interventions
John Bradley Sorenson
Executive Vice President - Global Operations
Eric Francis Yves Thepaut
Executive Vice President and President - Europe, Middle East and Africa
Emily Woodworth
Senior Vice President, Chief Accounting Officer, Controller
Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Edward J. Ludwig
Lead Independent Director
David C. Habiger
Director
Charles J. Dockendorff
Independent Director
Yoshiaki Fujimori
Independent Director
Jessica L. Mega
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US1011371077
  • Market cap
    $150.86bn
  • Employees
    48,000
  • Shares in issue
    1.74bn
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.